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Abstract
Genetic differences both between individuals and populations are studied for their evolutionary relevance and for their
potential medical applications. Most of the genetic differentiation among populations are caused by random drift that
should affect all loci across the genome in a similar manner. When a locus shows extraordinary high or low levels of
population differentiation, this may be interpreted as evidence for natural selection. The most used measure of population
differentiation was devised by Wright and is known as fixation index, or FST. We performed a genome-wide estimation of FST
on about 4 millions of SNPs from HapMap project data. We demonstrated a heterogeneous distribution of FST values
between autosomes and heterochromosomes. When we compared the FST values obtained in this study with another
evolutionary measure obtained by comparative interspecific approach, we found that genes under positive selection
appeared to show low levels of population differentiation. We applied a gene set approach, widely used for microarray data
analysis, to detect functional pathways under selection. We found that one pathway related to antigen processing and
presentation showed low levels of FST, while several pathways related to cell signalling, growth and morphogenesis showed
high FST values. Finally, we detected a signature of selection within genes associated with human complex diseases. These
results can help to identify which process occurred during human evolution and adaptation to different environments. They
also support the hypothesis that common diseases could have a genetic background shaped by human evolution.
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Introduction
Genetic differences are present in humans at both individual
and population level. Human genetic variations are studied for
their evolutionary relevance and for their potential medical
applications. This studies can help scientists in understanding
ancient human population migrations as well as how selective
forces act on the human being [1,2].
According to the theory of neutral variation, most of the genetic
variability within species are caused by random drift of selectively
neutral polymorphic alleles [3]. Genetic drift should affect all loci
across the genome in a similar manner. Therefore, when a locus
shows extraordinary high or low levels of variability this may be
interpreted as evidence for natural selection [4]. High levels of
population differentiation can suggest the acting of a positive
selection of advantageous alleles in one or more populations. On
the contrary, lower levels of population differentiation can be
considered as the effect of balancing selection that tends to
maintain a constant proportion of alleles across all populations [5].
Population differentiation is sensitive to a variety of demo-
graphic factors (including the rate of drift within populations and
the extent of gene flow among them), making it difficult to rule out
demographic scenarios that could account for the observed
variations. Another class of tests is aimed to detect signature of
natural selection by comparing data from different species. These
tests explore the fact that mutations can be synonymous and non
synonymous, and that non-synonymous mutations are more likely
to have an effect on individual fitness. This method is also known
as dN/dS. Results obtained by this comparative approach are
rarely interpreted in terms of population genetics theory [6].
The human population is also not homogeneous in terms of
disease susceptibility. Risks of common diseases are substantially
different among ethnic groups [7]. The understanding of
population genetic differentiation, especially in genes associated
with diseases, can help to explain the observed variations in the
prevalence of diseases. It is not difficult to forecast that, in the
future, genetic structure of populations can be used in public
health management [8]. Moreover, natural selection on genes that
underlie human disease susceptibility has been invoked. In this
framework, ancestral alleles reflect ancient adaptation. With the
shift in the environment, these alleles increase the risk for common
diseases [9].
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ation have been elaborated [10–16]. One of the most used is a
measure devised by Wright and known as fixation index, or FST
[17,18], which is the amount of genetic variation among groups
relative to a panmictic state. As a testof selection, observed FST values
are compared to those expected under neutrality. The main difficulty
of this approach is to determine the distribution of FST values under
neutrality [10]. Recently, however, the abundance of genetic data
available allows the creation of an empirical genome-wide distribu-
tion to be used for the comparisons. Rather than statistically testing
specific loci, we can use their position relative to this distribution to
gain insights about their selective histories. In addition, the
abundance of information about variability of many genes makes it
possible to analyze not only single genes, but also sets of functionally
related genes. International HapMap Project [19] by supplying data
of a large number of Single Nucleotide Polymorphisms (SNPs) across
many human populations, is providing an exceptional tool for
studying the genetic structure of human populations.
In the present article we report the results of a genome-wide
estimation of FST on 3,917,301 SNPs from the latest release of
HapMap data. Our results show a heterogeneous distribution of
FST values among genomic regions. Furthermore, we studied the
relationship between FST and an evolutionary measure obtained
by a comparative interspecific approach. We applied a gene set
approach, widely used for microarray data, to detect biochemical
pathways under selection. Finally, we detected a signature of
selection within genes associated with complex diseases.
Results
Using FST, we estimated populations differentiation for
3,917,301 SNPs in population samples from the International
HapMap Project data (Public release 27, merged II + III). To
retain the largest number of SNPs broadly reflecting a continental
subdivision, we used data from Yoruba (Africa), Japanese (Asia),
Han Chinese (Asia) and CEPH (European descendant) individuals.
Combining data from these populations we were able to compare
the largest set of genotyped SNPs up to now available. We pooled
Japanese and Han Chinese samples due to their geographical
closeness. Furthermore, this pooling allowed us to compare our
data with previous studies [20,11]. FST was estimated according to
Weir and Cockerham [18,21].
After exclusion for Minor Allele Frequency (MAF), we obtained a
final SNP sample of 2,125,440SNPs. The mean FST was 0.122 (SE
=5 610
25, median =0.091, interquartile range =0.131; see
Supporting Information S1 for more detailed statistics). Figure 1
shows distribution of FST values for each chromosome. The median
FST values of SNPs on the autosomal and sexual chromosomes were
statistically different (Kruskal-Wallis test, p-value ,10
216). The
median FST values for X and Y chromosomes were 0.129 (mean
=0.174) and 0.676 (mean =0.606) respectively and were notably
higher than those of autosomal chromosomes. Also medians
between autosomal chromosomes showed significant differences,
but in a very small range of values (median range =0.084 to 0.098).
For each chromosome, we computed the correlations of all pairs
of FST values for neighbouring SNPs separated by a fixed number
of SNPs (1 to 30). This method is commonly used to assess whether
FST values are non randomly distributed across chromosomes
[4,22]. As expected, we found that correlation plots are different
from those expected from a noisy signal (Figure 2). Moreover,
scrambling FST values across each chromosome produced
vanishing correlation values demonstrating that the distribution
of data is non-random (data not shown). This result was also
supported by a test for non-randomness of data (Ljung-Box test,
p-value ,10
216). Figure 2 shows a clear difference between
correlation plots of autosomal and X-linked SNPs, the latter
showing higher autocorrelation values. Chromosome Y was
excluded from this analysis because of the small number of SNPs
sampled.
To attribute FST value to genes we followed the approach by
Akey et al. and Pikrell et al. [4,16], considering FST of a gene the
Figure 1. Distribution of FST values across chromosomes. For
each chromosome, the box length is the interquartile range while the
horizontal line inside it is the value of the median. The whiskers extend
to the most extreme data point ,1.5 times the interquartile range from
the box. Extremes of the notches represents 95% confidence interval of
the median.
doi:10.1371/journal.pone.0007927.g001
Figure 2. Correlation between FST values. The correlation is
calculated, for each chromosome, for all pairs of SNPs separated by a
fixed number of intervening SNPs. Black line shows mean value and 2s
error bars of the correlation of SNPs belonging to autosomal
chromosomes. Red line shows correlation among X-linked SNPs.
doi:10.1371/journal.pone.0007927.g002
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Methods). It is worth stressing that this approach is very
conservative for genes with low FST values.
Selection affects both interspecific (between-species) and
intraspecific (within-species) variability. FST is a measure of
intraspecific variability. Estimation of genic dN/dS is an interspe-
cific measure of variability [6]. We compared the gene FST values
that we obtained with previously reported data from a genome-
wide estimation of genic dN/dS [23]. In that article the authors
divided genes into subgroups with strong, weak and no evidence of
positive selection. We compared FST values of genes belonging to
these subgroups. Genes with both weak and strong evidence of
positive selection showed lower FST values than genes with no
evidence of positive selection (ANOVA, p-value ,0.001; Bonfer-
roni post-hoc, no evidence vs. weak evidence p-value ,0.02, no
evidence vs. strong evidence p-value ,0.005, weak evidence vs.
strong evidence = N.S.; Figure 3).
To identify functionspotentially under selective pressure, we used
an innovative approach, focusing on gene pathways instead of
outliers. We performed this ‘‘gene set’’ analysis using the Gene Set
Enrichment Analysis (GSEA) algorithm [24,25]. GSEA is oriented
to identify sets of functionally related genes and is currently used in
the analysis of microarray data. Screening the KEGG pathway
database by GSEA, we identified 6 KEGG pathways enriched by
genes with high values of FST and one pathway enriched by genes
withlowvalues ofFST (Table1).In this method, the enrichment of a
pathway is mainly driven by a group of genes that are called
‘‘leading edge genes’’ (see Material and Methods). Figure 4 shows
the leading edge genes for the six pathways with high FST values. A
partial overlap of genes among pathways is present.
We then studied populations differentiation of genes associated
with complex diseases. We used the Genetic Association Database
(GAD) to select genes annotated as having positive association with
complex diseases. We compared FST values of these genes with those
where no association had been positively found. Genes associated
with complex diseases showed a significant higher mean value of FST
(t-test, p-value ,0.001; Moving Block Boostrap, empirical p-value
=0.0005; Figure 5). Then, we divided diseases in subgroups
according to the GAD classification of diseases. Figure 6 shows that
largedifferencesofFST values existamong disease classes,while mean
FST values are usually higher than those of non associated genes.
Discussion
The study of the evolutionary forces acting in diseases and
physiological traits is an exciting field that may drive further
researches and, in the future, public health policies. The study of
population genetic differentiation could help the understanding of
human evolution, demographic history and disease susceptibility
[26]. To study population differentiation we performed a genome-
wide FST calculation using the latest available data release from
the HapMap. Using this release we were able to increase both the
number of SNPs and the number of individuals analysed in
comparison to recent analogous studies [15]. We focused on
samples from three different continents (Africa, Asia, Europe) to
obtain a broad but sound measure of populations differentiation.
We found an overall mean FST value (0.122) broadly consistent
with previous estimations [4,22,15]. The slightly higher value that
we obtained could be explained by the exclusion of SNPs with MAF
,0.05 and the inclusion of heterochromosomes in the calculation.
Indeed, as expected [4], we observed a significantly higher median
FST value of X-linked SNPs with respect to the autosomal ones.
Furthermore, we found median FST value of Y-linked SNPs to be
significantly higher than both the autosomal and the X-linked ones.
Previous data from smaller datasets suggested a similar phenom-
enon [27], but, in our knowledge, this is the first observation made
on Y chromosome FST in a more robust framework. The higher
population differentiation for X and Y chromosomes can be due to
various causes: their smaller effective population size (three-quarter
andone-quarter of autosomes,respectively), the lower mutationand
recombination rates and the different selective pressure between
genders have been invoked [4,6,28].
Keinan et al. showed that there was a period of accelerated
genetic drift on chromosome X associated with the human
dispersal out of Africa. In particular, they estimated the autosome-
to-X genetic drift ratio between North Europeans and East Asians
is consistent with the expected 3/4 while it is significantly reduced
between North Europeans and West Africans, and between East
Asians and West Africans [29]. As possible explanations they
suggested that a gender-biased process reduced the female
Figure 3. Mean FST value of genes with and without interspe-
cific evidence of positive selection. Genes were grouped according
to the strength of evidence of their positive selection across six species
[23]. Vertical bars represent 95% confidence interval.
doi:10.1371/journal.pone.0007927.g003
Table 1. Enriched KEGG pathways identified by GSEA.
Pathway Name KEGG ID Size FDR
Enriched by high FST genes
Axon guidance HS04360 126 ,0.001
Focal adhesion HS04510 194 0.008
ECM receptor interaction HS04512 85 0.009
Regulation of actin
cytoskeleton
HS04810 199 0.010
Adherens junction HS04520 75 0.010
Calcium signaling pathway HS04020 168 0.010
Enriched by low FST genes
Antigen processing and
presentation
HS04612 70 0.001
For each pathway is showed the name, the KEGG ID, the number of genes
included in the pathway and the p-value after the False Discovery Rate (FDR)
correction.
doi:10.1371/journal.pone.0007927.t001
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affecting chromosome X was associated with the founding of non-
African populations. Our results are consistent with these finding.
We computed population pair-wise FST and we found that the
autosome-to-X genetic drift ratios (Q), estimated as in [29], are
compatible with those reported in [29] (Asia-Europe Q=0.72;
Asia-Africa Q=0.66; Europe-Africa Q=0.65).
The weak but significant correlation that we found among FST
values of neighbouring markers demonstrated that they are non-
randomly distributed along chromosomes. This result confirms
previous observations made on smaller datasets [4,22]. We
extended for the first time this observation to the X chromosome
and we found that correlation was slightly stronger than that of
autosomes. It has been observed that correlation between SNPs is
proportional to Linkage Disequilibrium (LD) [22]. Therefore, the
higher value of autocorrelation that we found can be explained by
the higher value of LD in X chromosomes [22].
Population genetics approach has been largely used for studying
natural selection. Other approaches include the comparative one,
in which data from different species are used. The most commonly
Figure 4. Leading edge genes of the high FST enriched KEGG pathways identified by GSEA. Genes are indicated by gene symbols. Red
box marks the presence of that gene, as leading edge gene, in that pathway.
doi:10.1371/journal.pone.0007927.g004
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per nonsynonymous site to the number of synonymous mutations
per nonsynonymous site (dN/dS). Data from comparative studies
and from population genetics are poorly connected. We found that
genes with a high dN/dS ratio, indicating positive selection,
showed a significantly lower FST mean value. In our knowledge
this represents the first attempt to connect human population
genetic data and comparative data at a genome-wide level. Our
finding does not conflict with previous studies performed on a
restricted number of genes [30]. It is well established that
comparative data provides the most unambiguous evidence for
selection, but relatively vague assertion on the type of selection and
if the selection is currently acting in a population [6]. For such
reasons the connection with population genetic data is needed.
Further studies, mainly focused on this topic, are required to
confirm and understand the relationship that we found.
We used a gene set approach to identify pathways with
extraordinary levels of population genetic differentiation. The
traditional approach used to perform this analysis is based on the
identification of those loci outliers in a given statistic. This
approach has been recently reviewed and its limits explored
[10,31–33]. Interestingly, similar criticisms are arising on analo-
gous methods used in transcriptomic data analysis. In this field,
alternative approaches, as the ‘‘gene set’’ ones, are gaining
increasing interest. Among the tools implementing this approach,
Gene Set Enrichment Analysis [34,25] is one of the most used
[35,36]. The key idea underlying GSEA is to focus on gene sets,
which are defined as groups of genes sharing common features
(e.g. biological pathways, chromosomal position, etc.). In micro-
array data analysis, GSEA aims to determine whether a gene set
shows statistically significant, concordant differences between two
biological states or phenotypes. This method has been tailored for
microarray data, however its use is being explored also in different
fields [37,38]. To the best of our knowledge, the present report is
the first attempt to functionally analyse genes under selective
pressure by a gene set statistical approach.
Figure 5. Mean FST value of genes associated to complex
diseases. Genes found positively associated with complex diseases
according to the Genetic Association Database are compared with the
remaining ones. Vertical bars represent 95% confidence interval.
doi:10.1371/journal.pone.0007927.g005
Figure 6. Mean FST values of genes in different disease classes. Genes were grouped according to the diseases classification of Genetic
Association Database. Vertical bars represent 95% confidence interval. Horizontal solid and dashed lines represent mean value and 95% confidence
interval of the set of non associated genes.
doi:10.1371/journal.pone.0007927.g006
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differential FST values on seven KEGG pathways, one enriched by
low FST genes and six enriched by high FST genes. However, it is
important to note that the discrepancy between the number of low
and high FST pathways is a consequence of the way by which we
attributed FST values to genes rather than underlying evolutionary
forces. The only pathway with decreased degree of differentiation
among populations was the ‘‘antigen processing and presentation’’
pathway. Included in this pathway are genes involved in the
antigen-presenting machinery as (i) the expression of major
histocompatibility complex (MHC) molecules, (ii) the mechanism
of cross-presentation, and (iii) the interaction of antigen-presenting
cells. Opposing views exist concerning the evolutionary forces that
shaped the innate immune system. In particular, the relative
impact of purifying and balancing selection is under discussion
[39,40]. Barreiro et al demonstrated that several SNPs of genes
related to the immune response to pathogens showed very high
FST values [15]. On the other hand, Akey et al. reported a four
times increase of proteins that perform a defense/immunity
function in the group of the low FST genes [4]. Moreover, low
levels of population differentiation have been previously detected
at loci that are involved with host–pathogen responses (HLA class
I and class II genes, beta-globin, G6PD, glycophorin A, interleukin
4 receptor-alpha and CCR5) [5]. Further evidence arises from the
group of genes that we studied and that were previously described
to be under positive selection. This group of genes, which we
found with low FST values, was described to be enriched for
several functions related to immunity and defence [23].
Among the six gene sets enriched by high FST genes, we found
the ‘‘calcium signalling’’ pathway.
Calcium is the most abundant mineral in the body. It is also a
highly versatile intracellular signal that regulates many cellular
processes in response to different external stimuli, as growth
factors [41]. We found very high FST values in three genes
belonging to the growth factor stimulated calcium signalling
pathway, namely EGFR, ERBB2, and ERBB4. It is interesting to
note that a previous study from Pickrell et al. found that ERBB4
showed extreme signs of haplotype selective sweep in non-African
populations [16]. The authors suggested that this gene could affect
an unidentified phenotype that experienced a strong recent
selection in non-African population. Our gene set approach seems
to confirm this finding and expands this observation to other
members of the ERBB gene family.
The other five high FST pathways are involved in the control of
cell shape and mobility. Among them, four interconnected
pathways (‘‘focal adhesion’’, ‘‘regulation of the actin cytoskeleton’’,
‘‘adherens junction’’ and ‘‘extra cellular matrix receptor interac-
tion’’) govern growth-related processes and morphogenesis.
Morphological traits have been demonstrated to show strong
signature of positive selection [15]. These pathways were found
also to be altered in a mouse model of fetal alcohol syndrome,
associated with a low birth-weight phenotype [42]. Indeed, human
body shape and size varies among populations showing a
correlation with geographic and climate variables [43]. In
addition, in the ‘‘adherens junction’’ pathway, one of the strongest
FST values was showed by TCF7L2, the gene with largest type 2
diabetes effect size found to date [44]. This last finding is
consistent with previous observations [44,16]. Since it has been
demonstrated that TCF7L2 variants also substantially influence
normal birth-weight variations [45], a complex interplay between
pathways that govern growth-related processes and susceptibility
to type 2 diabetes could be hypothesized.
The last high FST pathway, the ‘‘axon guidance’’, is involved in
brain wiring during foetal development and repair throughout life.
Axon guidance proteins and their relative binding partners have
also an emerging role in the pathogenesis of several neurodegen-
erative and psychiatric diseases such as schizophrenia [46,47].
Signature of recent positive selection inferred by identification of
selective sweeps in specific populations was found in genes involved
inschizophrenia[48].Moreover,populationdependentresultswere
obtained when gene-association studies were performed using
several high FST genes present in this gene set [49,50].
It has been suggested that alleles involved in common disease
could be targets of selection [51,9,52,43]. The common disease/
common variant (CD/CV) hypothesis proposes that common
diseases are usually caused by one or a few common disease
susceptibility alleles. These genetic variants represent ancestral
alleles, presumably under selective pressure, that have become
disadvantageous after changes in environment and of lifestyle
[51,53,54]. We found that genes associated with complex diseases
showed a significant higher mean value of FST, supporting the
CD/CV hypothesis. However, several previous studies of SNPs
associated with complex diseases did not find significant evidence
of population differentiation [55,56]. On the other hand, further
studies observed that the distribution of maximum FST was shifted
upward in regions associated with type 2 diabetes mellitus [16].
Moreover SNPs known to protect against obesity and diabetes
showed very high FST values [15]. Simulation studies also
provided support for the CD/CV hypothesis [57].
According to the GAD classification of diseases, we divided the
overall group of the genes associated with complex diseases. Clear
differences in FST means among the various classes were present.
In particular, several disease classes, namely ‘‘hematological’’,
‘‘infection’’, and ‘‘immune’’, showed an FST mean value slightly
lower than the mean value of non-associated genes. Nevertheless,
the majority of the classes showed FST mean values to be higher
than the non-associated one. Highest FST values were detected in
‘‘pharmacogenomics’’ and ‘‘psychiatric’’ classes. GAD classifies in
‘‘pharmacogenomics’’ those diseases related to drug effects. It is
well established that drugs effects are race/ethnic specific [58].
The GAD ‘‘psychiatric’’ class includes mental disorders. Why
genes that confer susceptibility to mental diseases are still
maintained by natural selection, is an old question which, up to
now, is still unanswered. The compensatory advantage for genes
associated to intermediate phenotypes has been invoked as
explanation for this phenomenon, also called ‘‘psychiatric
paradox’’ [59]. Further studies should be performed to determine
if the high level of population differentiation that we found for this
disease class could be related to the psychiatric paradox.
The results presented in this paper could contribute to further
explorations of the ongoing selection in humans. Further studies are
needed to clarify the biological pathways involved and to better
elucidate the role of natural selection in human complex diseases.
Materials and Methods
Data
All analysis are based on the HapMap Public Release #27
(merged II+III) datafiles (http://www.hapmap.org). We analyzed
the data from the CEPH (Utah residents with ancestry from
northern and western Europe; CEU, n=165), Yoruba in Ibadan,
Nigeria (YRI, n=167), Han Chinese in Beijing, China (CHB,
n=84) and Japanese in Tokyo, Japan (JPT, n=86) samples. We
pooled the CHB and JPT samples to form a single sample.
Additional SNP information about physical positions and SNP-
gene association were obtained from dbSNP build 129 (http://
www.ncbi.nlm.nih.gov/projects/SNP). In particular, according to
dbSNP classification, we considered all SNPs within 2 kb of a gene
Genome-Wide Scan for Selection
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International HapMap Project and dbSNP were merged in a
local MySQL database by a set of script from Amigo et al. [60].
When we consider the whole Hap map dataset (autosomes and
heterochromosomes) we analyzed a total of 3,917,301 SNPs.
We excluded by this analysis SNPs that were non sampled or
non polymorphic in all the three samples. We excluded also SNPs
with a minor allele frequency ,5% in any of the 3 samples, getting
a final SNP sample of 2,125,440 SNPs.
Estimates of FST
Fixation index (FST) was calculated using the unbiased estimator
proposed by Weir and Cockerham [18,21]. We implemented this
calculation in a Perl script available upon request by the authors.
All analyses presented in this work were also performed by using the
original FST estimator proposed by Wright [17] and results are almost
identical to that obtained by the Weir and Cockerham method. This
result is not surprising considering previous reports [61,4] and the
strong correlation that we found between these two measures
(Spearman’s r=0.97, p,10
216; see Supporting Information S1).
The maximum FST values among those of the SNPs associated
to the gene according to dbSNP (see above) was used to assign a
FST value to each gene. This approach is consistent with
previously described ones [4,16]. We studied the correlation
between FST value and gene length and we found that the former
have a quite marginal effect on the latter (R
2=0.2).
Statistical Analysis
SNPs FST values are not normally distributed across chromo-
somes. Thus to detect differences among medians FST values of
chromosomes we used the non-parametric Kruskal-Wallis test.
Conversely, FST values of genes are normally distributed
(Kolmogorov-Smirnov/Lilliefor test, p,0.001,) thus comparison
among these values were performed by using parametric tests
(ANOVA and t-test).
All statistical analyses were performed with R ver. 2.9 (R
Foundation for Statistical Computing, Vienna, Austria; http://
www.r-project.org/). Non-randomness of data was assessed by
using a Ljung-Box test (R function ‘‘Box.test’’). We calculated the
autocorrelation of each chromosome which can be seen as the
mean correlation of all pairs of FST values separated by a fixed
number of values (R function ‘‘acf’’).
A list of about 4000 genes positively selected was obtained from
the track ‘‘Positively Selected Genes’’ (database ‘‘hg18’’, table
‘‘mammalPsg’’) in UCSD Genome browser (http://genome.ucsc.
edu). This list was produced by a genome wide scan in six
mammalian genomes performed by Kosiol et al. [23]. In
particular they identified (i) 400 genes with strong evidence of
positive selection across species, (ii) 144 genes with strong evidence
of positive selection in one or more branches, (iii) 3705 genes with
weak evidence of positive selection on one or more branches, and
(iv) 12280 (orthologs) genes with no significant evidence of positive
selection. We pooled first and second group into a single ‘‘strong
evidence of positive selection’’ group. Differences among groups
were evaluated by ANOVA with Bonferroni post-hoc calculation.
Genes associated with complex diseases were obtained from the
Genetic Association Database (GAD; October 1 2007 update;
http://geneticassociationdb.nih.gov). We only kept genes with
positive evidence of association, for a total of 1789 genes.
According to GAD, these genes are divided into 15 classes of
diseases. We excluded from the analysis four diseases classes
(Other, Unknown, Mitochondrial and Normal variations) because
they were not informative. Differences among groups were
evaluated by a t-test and a resampling approach. In particular,
we used a Moving Block Boostrap (MBB) strategy [62]. Briefly, (i)
we resampled 10000 times 1789 set of adjacent SNPs {ni}j with
i=1, …,1789 and j=1, …,10000 and with each set ni having the
same number of SNPs as the i-th GAD associated gene; (ii) for
each resample, we computed the FST of each set ni according to
our method (the maximum FST values among those of the SNPs in
the set); then, (iii) we computed the mean FST value of each
resample j obtaining a distribution to which compare the mean
FST value of the GAD associated genes.
Functional Analysis
We used Gene Set Enrichment Analysis (GSEA) 2.0 [63] to detect
KEGG pathways enriched by genes with low or high values of FST.
We provided GSEA, by its ‘‘Preranked’’ feature, with a list L of genes
ranked according to their FST value. Given an a priori defined set of
genes S representing a pathway (e.g., genes encoding products in a
metabolic pathway), the goal of GSEA is to find out whether the
members of S are randomly distributed throughout L or mainly found
at the top or bottom (i.e. being ‘‘enriched’’). Since GSEA preferably
expect the values to rank for (in our case FST) to vary from negative to
positive values, we linear shifted these values to get vanishing mean.
We explored the enrichment of KEGG pathways included in the
software. For each pathway a False Discovery Rate (FDR) is
computed, representing the statistical significance of the enrich-
ment. For experimental conditions similar to the ours, GSEA user’s
guide suggests a threshold of significance FDR #0.05. Because of
the exploratory nature of this study, we used a more conservative
threshold of significance (FDR #0.01). Overlap among pathways
was examined by the ‘‘Leading edge analysis’’ feature of GSEA.
Supporting Information
Supporting Information S1 Additional figures and tables
Found at: doi:10.1371/journal.pone.0007927.s001 (1.07 MB
PDF)
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